|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 14/59 | |||
| C07K 16/00 | |||
| C07K 16/28 | |||
| C07K 16/30 | |||
| C12N 5/10 |
| (11) | Number of the document | 2428224 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11176197.9 |
| Date of filing the European patent application | 2007-09-10 | |
| (97) | Date of publication of the European application | 2012-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
| (46) | Date of publication of the claims translation |
| (72) |
Goletz, Steffen, DE
Danielczyk, Antje, DE
Baumeister, Hans, DE
Stahn, Renate, DE
Löffler, Anja, DE
Stöckl, Lars, DE
|
| (73) |
Glycotope GmbH,
Robert-Rössle-Strasse 10, 13125 Berlin,
DE
|
| (54) | USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES |
| USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES |